German Gynecological Oncology Group (AGO) Recognizes BluePrint® in Breast Cancer Guidelines lelezard.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lelezard.com Daily Mail and Mail on Sunday newspapers.
The final data set from NeoDynamics’ PULSE study shows favorable safety and efficacy profile of NeoNavia for ultra-sound guided biopsies in the axillary lymph nodes. The data are being presented. | May 5, 2023
/PRNewswire/ Data from the NeoDynamics PULSE study with its biopsy device NeoNavia shows a success rate of 96% in very complex and risky axilla biopsies..
/PRNewswire/ NeoDynamics AB (Spotlight Stock Market: NEOD), a medtech company dedicated to advancing diagnosis and care of breast cancer, will present.
/PRNewswire/ NeoDynamics AB (Spotlight Stock Market: NEOD), a medtech company dedicated to advancing diagnosis and care of breast cancer, will present.